NASH and the Gut Microbiome: Implications for New Therapies
Cynthia J. Tsay, Joseph K. Lim – 27 January 2022
Seeking editor for Clinical Liver Disease
26 January 2022
Issue Information
26 January 2022
Male‐Specific Activation of Lysine Demethylases 5B and 5C Mediates Alcohol‐Induced Liver Injury and Hepatocyte Dedifferentiation
Michael Schonfeld, Janice Averilla, Sumedha Gunewardena, Steven A. Weinman, Irina Tikhanovich – 26 January 2022 – Alcohol‐associated liver disease (ALD) is a major cause of alcohol‐related mortality. Sex differences in sensitivity to ALD are well described, but these are often disregarded in studies of ALD development. We aimed to define sex‐specific pathways in liver exposed to alcohol. Mice were fed the Lieber‐DeCarli alcohol liquid diet or a combination of a high‐fat diet with alcohol in water.
Letter to the editor: Hepatocyte proliferation peak and β‐oxidation in liver regeneration after partial hepatectomy
Fuchen Liu, Wenli Zhang, Hui Liu – 25 January 2022
Reply
Zoe Hall, Fiona Oakley, Michele Vacca, Julian L. Griffin – 25 January 2022
Will inhibition of cellular crosstalk resolve liver fibrosis?
Edward N. Harris – 25 January 2022
Zac1 and the Imprinted Gene Network program juvenile NAFLD in response to maternal metabolic syndrome
Marine Baptissart, Christine M. Bradish, Brie S. Jones, Evan Walsh, Jesse Tehrani, Vicmarie Marrero‐Colon, Sanya Mehta, Dereje D. Jima, Seh Hoon Oh, Anna Mae Diehl, Tiffany Fougeray, Hervé Guillou, Michael Cowley – 25 January 2022
LiverLearning®: Addiction Medicine for Liver Care Providers
DESCRIPTION There is growing interest among hepatology providers in incorporating addiction medicine skills in the evaluation of patients with addiction-related liver diseases, particularly alcohol-associated liver disease. Recent studies have shown an association between receipt of addiction treatment and improvements in liver-related outcomes in patients with alcohol-associated liver disease.
Reply
James M. Paik, Linda Henry, Zobair M. Younossi – 24 January 2022